New Square Capital LLC Biocryst Pharmaceuticals Inc Transaction History

New Square Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$3.37 - $8.61 $3,370 - $8,610	-1,000 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$3.43 - $5.53 $583 - $940	-170 Reduced 14.53%	1,000 $3,000
Q2 2020 Aug 05, 2020	SELL	$1.9 - $5.61 $1,577 - $4,656	-830 Reduced 41.5%	1,170 $6,000
Q1 2020 May 08, 2020	SELL	$1.6 - $4.11 $8,800 - $22,605	-5,500 Reduced 73.33%	2,000 $4,000
Q4 2019 Jan 10, 2020	BUY	$1.59 - $3.45 $11,925 - $25,875	7,500 New	7,500 $26,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.